Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 633

1.

Twenty-millisecond interventricular difference as assessed by body surface potential mapping identifies patients with clinical improvement after implantation of cardiac resynchronization device.

Samesima N, Douglas R, Tobias N, Pedrosa A, Martinelli Filho M, Ramires JA, Pastore CA.

Anadolu Kardiyol Derg. 2007 Jul;7 Suppl 1:213-5.

2.

Ventricular electrical activation in cardiac resynchronization as characterized by body surface potential mapping.

Pastore CA, Tobias N, Samesima N, Martinelli Filho M, Pedrosa A, Nishioka S, Douglas RA, Moreira LF, Ramires JF.

Arq Bras Cardiol. 2007 Mar;88(3):251-7. English, Portuguese. Erratum in: Arq Bras Cardiol. 2007 Apr;88(4):499.

3.

Repercussions of cardiac resynchronization therapy on the ventricular repolarization of heart failure patients as assessed by body surface potential mapping.

Pastore CA, Douglas RA, Samesima N, Martinelli Filho M, Nishioka SD, Kaiser E, Ramires JA.

Anadolu Kardiyol Derg. 2007 Jul;7 Suppl 1:79-81.

4.

Body surface potential mapping investigating the ventricular activation patterns in the cardiac resynchronization of patients with left bundle-branch block and heart failure.

Pastore CA, Tobias N, Samesima N, Filho MM, Pedrosa A, Nishioka S, Douglas RA, Moreira LF, Ramires JF.

J Electrocardiol. 2006 Jan;39(1):93-102. Epub 2005 Dec 1.

PMID:
16387060
5.

Electrical and mechanical components of dyssynchrony in heart failure patients with normal QRS duration and left bundle-branch block: impact of left and biventricular pacing.

Turner MS, Bleasdale RA, Vinereanu D, Mumford CE, Paul V, Fraser AG, Frenneaux MP.

Circulation. 2004 Jun 1;109(21):2544-9. Epub 2004 May 17.

6.

Cardiac resynchronization therapy in patients with intrinsic and right ventricular pacing-induced left bundle branch block pattern.

Shen X, Aronow WS, Holmberg MJ, Li H, Nair CK, Korlakunta H, Esterbrooks DJ.

Am J Ther. 2009 Nov-Dec;16(6):e44-50. doi: 10.1097/MJT.0b013e3181788cc6.

PMID:
19940605
7.

Biventricular pacemaker upgrade in previously paced heart failure patients--improvements in ventricular dyssynchrony.

Witte KK, Pipes RR, Nanthakumar K, Parker JD.

J Card Fail. 2006 Apr;12(3):199-204.

PMID:
16624685
9.

Right and left ventricular activation sequence in patients with heart failure and right bundle branch block: a detailed analysis using three-dimensional non-fluoroscopic electroanatomic mapping system.

Fantoni C, Kawabata M, Massaro R, Regoli F, Raffa S, Arora V, Salerno-Uriarte JA, Klein HU, Auricchio A.

J Cardiovasc Electrophysiol. 2005 Feb;16(2):112-9; discussion 120-1.

PMID:
15720446
10.

Effects of resynchronization therapy on cardiac function in pacemaker patients "upgraded" to biventricular devices.

Horwich T, Foster E, De Marco T, Tseng Z, Saxon L.

J Cardiovasc Electrophysiol. 2004 Nov;15(11):1284-9.

PMID:
15574179
12.

Global and regional ventricular repolarization study by body surface potential mapping in patients with left bundle-branch block and heart failure undergoing cardiac resynchronization therapy.

Douglas RA, Samesima N, Filho MM, Pedrosa AA, Nishioka SA, Pastore CA.

Ann Noninvasive Electrocardiol. 2012 Apr;17(2):123-9. doi: 10.1111/j.1542-474X.2012.00500.x.

PMID:
22537330
13.

Effect of right ventricular lead location on response to cardiac resynchronization therapy in patients with end-stage heart failure.

Haghjoo M, Bonakdar HR, Jorat MV, Fazelifar AF, Alizadeh A, Ojaghi-Haghjghi Z, Esmaielzadeh M, Sadr-Ameli MA.

Europace. 2009 Mar;11(3):356-63. doi: 10.1093/europace/eun375. Epub 2009 Jan 9.

14.

The benefit of upgrading chronically right ventricle-paced heart failure patients to resynchronization therapy demonstrated by strain rate imaging.

Eldadah ZA, Rosen B, Hay I, Edvardsen T, Jayam V, Dickfeld T, Meininger GR, Judge DP, Hare J, Lima JB, Calkins H, Berger RD.

Heart Rhythm. 2006 Apr;3(4):435-42.

PMID:
16567291
15.

Cardiac resynchronization therapy in patients with chronic heart failure: pathophysiology and current experience.

Seidl K, Rameken M, Vater M, Senges J.

Am J Cardiovasc Drugs. 2002;2(4):219-26. Review.

PMID:
14727967
16.

Cardiac resynchronization therapy in patients with end-stage inotrope-dependent class IV heart failure.

Herweg B, Ilercil A, Cutro R, Dewhurst R, Krishnan S, Weston M, Barold SS.

Am J Cardiol. 2007 Jul 1;100(1):90-3. Epub 2007 May 15.

PMID:
17599447
17.

Effects of cardiac resynchronization therapy on ventricular repolarization in patients with congestive heart failure.

Berger T, Hanser F, Hintringer F, Poelzl G, Fischer G, Modre R, Tilg B, Pachinger O, Roithinger FX.

J Cardiovasc Electrophysiol. 2005 Jun;16(6):611-7.

PMID:
15946359
18.

Feasibility, safety, and mid-term efficacy of cardiac resynchronization therapy in patients with severe heart failure and ventricular conduction delay: Chulalongkorn experience.

Sunsaneewitayakul B, Sitthisook S, Sangwatanaroj S, Prechawat S, Songmuang SB.

J Med Assoc Thai. 2007 Jul;90(7):1458-66.

PMID:
17710992
19.

Prospective validation of stress echocardiography as an identifier of cardiac resynchronization therapy responders.

Da Costa A, Thévenin J, Roche F, Faure E, Roméyer-Bouchard C, Messier M, Convert G, Barthélemy JC, Isaaz K.

Heart Rhythm. 2006 Apr;3(4):406-13.

PMID:
16567286
20.

Long-term effectiveness of cardiac resynchronization therapy in patients with refractory heart failure and "narrow" QRS.

Achilli A, Sassara M, Ficili S, Pontillo D, Achilli P, Alessi C, De Spirito S, Guerra R, Patruno N, Serra F.

J Am Coll Cardiol. 2003 Dec 17;42(12):2117-24.

Items per page

Supplemental Content

Write to the Help Desk